It is known that KLF4 may act as an oncogene in osteosarcoma [218] by mechanisms involving Wnt/β-catenin, Notch, and EMT, despite that it seems to not have a relevant prognostic role in some tumors [219]. This evidence concerns the gene KLF4 and osteosarcoma.